UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 103 filers reported holding UROGEN PHARMA LTD in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $145,564 | +1897.6% | 10,390 | +1375.9% | 0.01% | – |
Q2 2023 | $7,287 | +45443.8% | 704 | -60.4% | 0.00% | -100.0% |
Q1 2023 | $16 | +6.7% | 1,778 | +2.1% | 0.00% | 0.0% |
Q4 2022 | $15 | -99.9% | 1,741 | -26.8% | 0.00% | – |
Q3 2022 | $20,000 | -4.8% | 2,378 | -5.4% | 0.00% | – |
Q2 2022 | $21,000 | +133.3% | 2,513 | +130.8% | 0.00% | – |
Q1 2022 | $9,000 | -57.1% | 1,089 | -50.6% | 0.00% | – |
Q4 2021 | $21,000 | +110.0% | 2,205 | +267.5% | 0.00% | – |
Q3 2021 | $10,000 | -80.0% | 600 | -81.8% | 0.00% | -100.0% |
Q2 2021 | $50,000 | -43.2% | 3,294 | -27.6% | 0.00% | 0.0% |
Q1 2021 | $88,000 | -14.6% | 4,550 | -20.0% | 0.00% | -66.7% |
Q4 2020 | $103,000 | -74.7% | 5,688 | -73.0% | 0.00% | -40.0% |
Q3 2020 | $407,000 | +450.0% | 21,096 | +644.7% | 0.01% | +66.7% |
Q2 2020 | $74,000 | +270.0% | 2,833 | +375.3% | 0.00% | +50.0% |
Q4 2019 | $20,000 | -57.4% | 596 | -70.2% | 0.00% | -33.3% |
Q3 2019 | $47,000 | +1075.0% | 2,000 | +1500.0% | 0.00% | – |
Q2 2019 | $4,000 | -96.4% | 125 | -95.8% | 0.00% | -100.0% |
Q1 2019 | $110,000 | +633.3% | 2,979 | +768.5% | 0.01% | +600.0% |
Q4 2018 | $15,000 | -53.1% | 343 | -50.1% | 0.00% | -50.0% |
Q3 2018 | $32,000 | +357.1% | 687 | +397.8% | 0.00% | – |
Q2 2018 | $7,000 | -30.0% | 138 | -29.9% | 0.00% | -100.0% |
Q1 2018 | $10,000 | 0.0% | 197 | -38.1% | 0.00% | 0.0% |
Q3 2017 | $10,000 | +100.0% | 318 | +14.0% | 0.00% | 0.0% |
Q2 2017 | $5,000 | – | 279 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 2,620,545 | $36,713,835 | 6.69% |
Wildcat Capital Management, LLC | 495,606 | $6,943,440 | 2.79% |
SILVERARC CAPITAL MANAGEMENT, LLC | 508,883 | $7,129,451 | 2.16% |
Opaleye Management Inc. | 320,000 | $4,483,200 | 1.46% |
AlphaCentric Advisors LLC | 165,000 | $2,311,650 | 1.31% |
Soleus Capital Management, L.P. | 372,000 | $5,211,720 | 0.48% |
EAM Investors, LLC | 170,523 | $2,389,027 | 0.46% |
RA Capital Management | 1,483,697 | $20,786,595 | 0.41% |
Parkman Healthcare Partners LLC | 145,311 | $2,035,807 | 0.37% |
MENORA MIVTACHIM HOLDINGS LTD. | 2,303,031 | $32,265,464 | 0.29% |